IMU 0.00% 4.9¢ imugene limited

I do find it strange given the clinical trial data for HER-Vaxx...

  1. 27,397 Posts.
    lightbulb Created with Sketch. 1781
    I do find it strange given the clinical trial data for HER-Vaxx were very good. Maybe PH deprioritise HER-Vaxx as he want the clinical trial for the other IP to also be as developed so BP will offer a lot more to buy everything.......
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.